Evaluation of the link between blood glucose levels and neurocardiogenic syncope in adults who experience fainting episodes.

Not Applicable

Completed

• Conditions: eurocardiogenic syncope; Hypoglycemia; Neurocardiogenic syncope; Cardiovascular - Other cardiovascular diseases; Metabolic and Endocrine - Metabolic disorders; Neurological - Other neurological disorders

• Registration Number: ACTRN12616000431426
• Lead Sponsor: Dr Angas Hamer

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Referred for Tilt Table Testing for syncopal events.
Participants will be over 18 years of age
Willing and able to sign an informed consent form

Exclusion Criteria

Those who are diabetic,
Those that are taking medication that interferes with blood glucose levels.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The evaluate the change in circulating blood glucose levels in response to syncope.[Ee will be checking the patient's venous blood glucose level at the following time points:<br>-Before the test begins (Baseline)<br>-After the first part of the tilt (after 10minutes)<br>-2 minutes after the Isoprenaline infusion part of the test has commenced<br>-After the end of the Isoprenaline phase of the test (End of test)]

Secondary Outcome Measures

Name	Time	Method
To analyse the blood glucose levels of participants in Tilt Table Testing who have a positive result on the test (ie hypotension) and compare the blood glucose levels to those who have a negative result, to see if any change in blood glucose levels can be related to the occurrence of hypotension itself rather than other aspects of the test. [We will be checking the patient's venous blood glucose level at the following time points:<br>-Before the test begins (Baseline)<br>-After the first part of the tilt (after 10minutes)<br>-2 minutes after the Isoprenaline infusion part of the test has commenced<br>-After the end of the Isoprenaline phase of the test (End of test)]